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Background/aim: Infection with the human papillomaviruses (HPVs) is associated with the development of several cancers, including
oral, esophageal, skin, lung, and cervical. However, the association of HPVs and colorectal cancers remains controversial. The aim of
this study was to evaluate the association between HPV infection and paraffin-embedded colorectal tissue samples in Mashhad in the
northeast of Iran.
Materials and methods: Paraffin-embedded tissue specimens from 111 patients with colorectal cancer were subjected to DNA
extraction. The quality of extracted DNA was confirmed by amplification of a β-globin fragment using polymerase chain reaction (PCR)
and GH20/PCO4 primers. PCR with GP5+/GP6+ primers was then performed on positive samples to evaluate the sequence of HPVs.
Results: A total of 100 colorectal samples with positive results for the β-globin gene were analyzed. The age of patients ranged from 18
to 72 years (mean: 52). Sixty-four patients (56.7%) were male and 47 patients (43.4%) were female. One (1%) out of 100 patients with
colorectal cancer was found to be positive for HPV DNA.
Conclusion: Results of the current study suggested that HPV infection is not common in patients with colorectal cancer in our
population. We concluded that HPV types that are associated with malignant transformations do not meaningfully contribute to
adenocarcinoma of the colon among our population.
Key words: Human papillomaviruses, colorectal cancer, paraffin-embedded specimens

1. Introduction
In 2008, colorectal cancer was reported to be the second
and third most common type of malignant cancers among
women and men, respectively. In 2008, globally, of about
1.23 million new cases of colon cancers, about 608,000
people died (1). According to some heredity studies, about
20% of patients who suffer from this type of cancer have a
family history. The presence of at least 2 patients suffering
from colorectal cancer in a family accelerated the risk of
incidence by 2 to 3 times (2), whereas some other studies
showed that 75% to 95% of the cases of colon cancers were
found in people who had no genetic history of this type
of cancer. Some other factors such as age and sex are also
suggested to have a role. From this point of view, older men
are more susceptible to develop this type of cancer (3).
* Correspondence: meshkatz@mums.ac.ir

Some genetic factors that are assumed to be involved are
as follows (4): reduction in the activity of the apc tumor
suppressor gene functionally or physically; the K-ras gene,
which encodes some molecules that could further bind to
active or inactive guanosine triphosphate; reduction in the
activity of the tumor suppressor gene at 18q21; and late
stage mutagenesis of the TP53 gene in colorectal cancers.
Currently, the roles of some viruses, particularly
papillomaviruses, on colorectal cancers are under
investigation. These viruses can cause malignancy both
in animals and humans. Papillomaviruses are small
viruses lacking an envelope. They have nucleocapsids with
icosahedral symmetry and are 52–55 nm in size. Its capsid
contains 72 capsomeres. Density of virus particles in CsCl
is about 1.34 g/mL. The human papillomavirus (HPV)
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encodes 8 proteins. Six of these proteins are from the first
region of their genome (E1–E7) and are nonstructural,
while the rest (L1 and L2) encode the proteins of the
main capsid. L1 is a highly conserved protein in all
types of papillomaviruses and L2 has a key role in the
aggregation of the viral capsid. Humans are the only host
for papillomaviruses. HPVs attack the skin, oral mucosa,
pharynx, trachea, and mucosa of the bronchi. According
to some recent studies, HPVs may also be involved in
esophageal carcinogenesis. Between 1995 and 2011,
many findings showed the association of HPV and colon
cancer (5–12); however, some other studies revealed that
there was no significant relationship between HPV and
colorectal cancers (13–15). The aim of this study was to
evaluate the frequency of HPVs in patients with colorectal
cancer in Mashhad, in the northeast of Iran.
2. Materials and methods
2.1. Sample collection and DNA extraction
Colorectal carcinoma specimens were obtained from
patients who were referred to the Pathology Department
of Imam Reza Hospital and Qaem Hospital in Mashhad,
Iran. After approval of the study by the research ethics
committee and informed written consent by patients, a total
of 111 colorectal carcinoma specimens were obtained. Five
sections of 10–20 µm of the paraffin-embedded samples
were prepared and the xylene-ethanol method was used
for deparaffinization of the samples. Tissue digestion was
performed using digestion buffer, which consisted of TrisCl (100 mM, pH 7.5) and Tween-20 (0.05%) as described
previously (16). Prepared samples were used directly for
polymerase chain reaction (PCR) amplification without
more purification steps.
2.2. PCR of β-globin gene used to check the quality of
extracted DNA
In the current study, the quality of extracted DNA from
paraffin-embedded tissue samples was determined by the
amplification of a 260-bp fragment of the β-globin gene
as an internal control. The PCO4 and GH20 primers were
used for the PCR amplification. The PCR reaction mixture
contained 0.8 µL (~1 µg) of DNA, 0.4 µL of dNTP (10 mM),
0.8 µL of Taq DNA polymerase (5 U/µL, CinnaGen, Iran),
2.5 µL of 10X PCR buffer, 1.6 µL of MgCl2 (25 mM), and
10 pmol/µL of each primer, in a total reaction volume of
25 µL. The PCR amplification was performed for 35 cycles
(94 °C for 30 s, 55 °C for 30 s, and 72 °C for 45 s) after an
initial denaturation step of 94 °C for 5 min. The cycles were
followed by a 5-min extension at 72 °C. The PCR product
was visualized on a 1.5% agarose gel by green viewer (Pars
Tous, Iran) staining and UV photography.
In order to determine the type of HPV
in
the
extracted
DNA
samples,
GP5+
(5´-TTTGTTACTGTGGTAGATACTAC-3´) and GP6+
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(5´-GAAAAATAAACTGTAAATCATATTC-3´) primers
were used to amplify a 142-bp fragment of L1 (a highly
conserved sequence of HPV gene). By performing this PCR,
almost all HPV types, including high- and low-risk types,
could be identified. The PCR reaction mixture consisted of
3 µL of DNA (100 ng/µL), 0.4 µL of dNTP (10 mmol), 0.3
µL of Taq DNA polymerase (5 U/µL, CinnaGen, Iran), 0.6
µL of MgCl2 (50 mmol), and 10 pmol/µL of each primer, in
a total volume of 25 µL. The PCR program was as follows:
denaturation for 5 min at 94 °C; 35 cycles of 94 °C for 45
s, 47.5 °C for 45 s, and 72 °C for 45 s; and a final extension
at 72 °C for 10 min. Fragment sizes of PCR products were
determined by comparison with appropriate molecular
weight marker in a 1.5% agarose gel.
2.3. Statistical analysis
Data were analyzed with SPSS 18 (SPSS Inc., Chicago, IL,
USA) and Fisher’s exact test. A P-value below 0.05 was
considered statistically significant.
3. Results
One hundred samples showed a 260-bp fragment in the
PCR. The positive samples were subjected to amplification
of a fragment of the highly conserved region of the L1 gene
of HPV (HPV L1). The results indicated that among 100
samples, only 1 sample (1.0%) showed a 142-bp fragment
of HPV L1. This sample could be considered as an HPVpositive sample. Patients’ ages ranged between 18 and
72 years and the mean age was 52. Among the patients,
64 (56.7%) were male and 47 (43.4%) were female. The
observed patient infected with HPV was a 60-year-old
woman. There was a relationship between the frequency
of patients with colorectal carcinoma and increase in age.
4. Discussion
Today colorectal cancer is considered as a common
cancer and many studies have been performed in this
regard. In 2011, Lorenzo et al. performed a metaanalysis
study of some papers that had been published during the
last 2 decades about the relationship between HPV and
colorectal cancer. They found that there was an association
between HPV and tumors (11). Liu et al. investigated the
prevalence of HPV in a Chinese population suffering from
colorectal cancer. Their results showed that the frequency
of HPV DNA found in tumor tissues was higher than in
nontumor colorectal tissues and peripheral blood samples
(P < 0.001) (10).
In a study performed by Damin et al. in 2007, the role of
HPV infection in colorectal cancer and prognostic factors
were evaluated. Their results showed that HPV DNA was
positive in 60 (83.3%) of the total 72 cancerous colorectal
samples. However, no HPV DNA was observed in any of
the noncancerous tissues (P < 0.001) (9).
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In another study, cancerous and normal tissues were
studied to assess the relationship between HPV DNA
and colorectal cancers. HPV DNA was found in 84% of
cancerous and 53% of normal mucosal tissues (7). In 1995,
Cheng et al. investigated the relationship between HPV
and colorectal cancer and their findings confirmed this
relationship (8). In 2010, Gornick et al.’s studies on frizzed
tumor tissues showed that HPV genotypes do not have a
role in adenocarcinoma colon cancer (13). This finding,
which is in agreement with the current study, suggested
that the prevalence of HPV was low in patients with
colorectal cancer. They also showed that different types of
HPV that are usually associated with malignant changes
were not found in patients who had suffered from colon
adenocarcinoma.
Although several studies confirmed the relationship
between HPV and colorectal cancer, others did not support
the association. This may have been caused by genetic,
geographical, and cultural differences of the patients in
different studies.

Most viruses, including papillomaviruses, need
dividing cells for their replication and the presence of
viruses in the replicating tumoral cells may have been
caused by this property of the cells. That is to say, they were
not involved in the carcinogenesis. One explanation for
the contradictory results in different studies is the previous
contamination of the patient with papillomaviruses and
tropism of the viruses to tumoral dividing cells rather than
the direct effect of the virus in carcinogenesis. Our results
showed that the frequency of human papillomaviruses
was low in the studied colorectal specimens. However,
further investigations with a much larger sample size are
required to validate the exact role of papillomaviruses in
the prevalence and progression of colorectal cancers.
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